Investment
Features
FeesSafety
Academy
More
Pluang+

Clarkson shares jump 8% after raising 2026 profit forecast on strong freight rates.

Company Fundamentals
06 Oct 2026
Proactive Investors
View Source
Bullish
Clarkson shares jump 8% after raising 2026 profit forecast on strong freight rates.

Clarkson PLC's shares rose as much as 8.4% following an upgrade to its full-year profit outlook for 2026, now expecting at least £135 million in underlying profit before tax. This upgrade was driven by strong trading in August and September, fueled by record freight rates in parts of the shipping market. Brokers Peel Hunt and Panmure Liberum responded positively, with Peel Hunt noting the new guidance is about 17% above consensus and implying significant profit growth in the second half of the year. Panmure Liberum raised its target price and profit forecast, highlighting strong market conditions benefiting Clarkson's Broking and Financial divisions, though it cautioned that the current freight market strength may not persist. Clarkson also noted increased geopolitical complexity has added volatility to commodity and freight markets, supporting freight rates and vessel asset prices.

Clarkson PLC shares jumped as much as 8.4% following a profit upgrade for 2026. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Oct 06, 2026 13:31 WIB: out of 93 priced US Industrials stocks, 62 rose and 28 fell. Notable movers include PAGS at USD 10.94 with a 21.29% increase and a typical hold time of 27 days, BYRN at USD 3.65 up 4.74%, and IR at USD 78.52 up 3.19%.

More News

Elon Musk confirms Terafab talks, expanding chip partners beyond Intel.

Elon Musk confirms Terafab talks, expanding chip partners beyond Intel.

Elon Musk has confirmed that his company is in discussions with Terafab, marking a potential new chip manufacturing partner alongside Intel, which has been the only named chip partner until now. This development could diversify the supply chain and e...

Market News
Neutral
1 hour ago
Verastem's cancer drug sales hit $25.1M in Q2 '26; key trial data expected in October

Verastem's cancer drug sales hit $25.1M in Q2 '26; key trial data expected in October

Verastem Inc. reported $25.1 million in net product revenues for Q2 2026 from its Avmapki Fakzynja Co-pack, used for certain ovarian cancer patients. The company is also developing a KRAS G12D inhibitor, VS-7375, targeting multiple cancers, with impo...

Market News
Bullish
4 hours ago
Radiant Uranium completes acquisition of Cross Lake uranium property in Saskatchewan.

Radiant Uranium completes acquisition of Cross Lake uranium property in Saskatchewan.

Radiant Uranium has finalized its acquisition of the 2,048-hectare Cross Lake uranium property in Saskatchewan's Athabasca Basin by issuing 4 million shares and paying $20,000 to Bromell Mining LLP. The property contains a historic uranium estimate o...

Company Fundamentals
Bullish
4 hours ago
Bitcoin down 32% a year after record high, milder than past crashes due to institutional flows and lower volatility

Bitcoin down 32% a year after record high, milder than past crashes due to institutional flows and lower volatility

One year after reaching a record high of over $126,000 in October 2025, Bitcoin's price has dropped just 32% to around $85,453, a much smaller decline compared to previous bear markets where drops ranged from 70% to over 80%. This milder downturn is ...

Market News
Neutral
4 hours ago
Solana launches Solana DvP, enabling instant on-chain trade settlements for institutions.

Solana launches Solana DvP, enabling instant on-chain trade settlements for institutions.

The Solana Foundation introduced Solana DvP, an open-source protocol that enables financial institutions to complete trade settlements on blockchain within seconds instead of days. Developed with guidance from JPMorgan, the protocol replaces fragment...

Protocol Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App